ATE344039T1 - Nicht-calcemische, transkriptionell-aktive, schwefelhaltige analoga von 1-alpha, 25- dihydroxyvitamin d3 mit antiproliferativer wirkung - Google Patents

Nicht-calcemische, transkriptionell-aktive, schwefelhaltige analoga von 1-alpha, 25- dihydroxyvitamin d3 mit antiproliferativer wirkung

Info

Publication number
ATE344039T1
ATE344039T1 AT00921523T AT00921523T ATE344039T1 AT E344039 T1 ATE344039 T1 AT E344039T1 AT 00921523 T AT00921523 T AT 00921523T AT 00921523 T AT00921523 T AT 00921523T AT E344039 T1 ATE344039 T1 AT E344039T1
Authority
AT
Austria
Prior art keywords
dihydroxyvitamin
calcemic
alpha
sulfur containing
transcriptionally active
Prior art date
Application number
AT00921523T
Other languages
English (en)
Inventor
Gary H Posner
Jae Kyoo Lee
Qiang Wang
Kenneth R Crawford
Gyoonhee Han
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Application granted granted Critical
Publication of ATE344039T1 publication Critical patent/ATE344039T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT00921523T 1999-04-01 2000-03-31 Nicht-calcemische, transkriptionell-aktive, schwefelhaltige analoga von 1-alpha, 25- dihydroxyvitamin d3 mit antiproliferativer wirkung ATE344039T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12732899P 1999-04-01 1999-04-01
US12847899P 1999-04-09 1999-04-09

Publications (1)

Publication Number Publication Date
ATE344039T1 true ATE344039T1 (de) 2006-11-15

Family

ID=26825543

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00921523T ATE344039T1 (de) 1999-04-01 2000-03-31 Nicht-calcemische, transkriptionell-aktive, schwefelhaltige analoga von 1-alpha, 25- dihydroxyvitamin d3 mit antiproliferativer wirkung

Country Status (13)

Country Link
US (1) US6380408B1 (de)
EP (2) EP1180035B1 (de)
JP (2) JP3630101B2 (de)
AT (1) ATE344039T1 (de)
CA (1) CA2366586C (de)
CY (1) CY1107548T1 (de)
DE (1) DE60031666T2 (de)
DK (1) DK1180035T3 (de)
ES (2) ES2274785T3 (de)
HK (1) HK1044293B (de)
MX (1) MXPA01009693A (de)
PT (1) PT1180035E (de)
WO (1) WO2000059513A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE428692T1 (de) * 2001-08-22 2009-05-15 Univ Johns Hopkins 24-schwefel-substituierte 1-alpha-25-dihydroxy- vitamin-d3-analogen
US6559138B1 (en) * 2001-09-21 2003-05-06 Syntex (U.S.A.) Llc 3-Desoxy-vitamin D3 analog esters
US7101865B2 (en) 2002-06-13 2006-09-05 Cytochroma Inc. 24-sulfoximine vitamin D3 compounds
CA2510228C (en) * 2002-12-18 2012-10-30 Johns Hopkins University 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3
CA2544502A1 (en) * 2003-11-25 2005-06-09 Wisconsin Alumni Research Foundation Vitamin d analogs for obesity prevention and treatment
WO2006074227A2 (en) * 2005-01-04 2006-07-13 Johns Hopkins University HIGHLY ANTIPROLIFERATIVE, LOW-CALCEMIC, ANALOGS OF THE HORMONE 1α, 25-DIHYDROXYVITAMIN D3 WITH CARBONYL SIDE CHAINS
US20090137828A1 (en) * 2005-08-18 2009-05-28 Bioxell S.P.A. Synthesis of 1A-Fluoro-25-Hydroxy-16-23E-Diene-26,27-Bishomo-20-Epi-Cholecalciferol
US20070122477A1 (en) * 2005-10-12 2007-05-31 Cytochroma, Inc. Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency
PT3095447T (pt) 2006-02-03 2022-01-24 Opko Renal Llc Tratamento da insuficiência e deficiência de vitamina d com 25-hidroxivitamina d2 e 25-hidroxivitamina d3
DK2037936T3 (da) 2006-06-21 2014-09-22 Opko Renal Llc Fremgangsmåde til behandling og forebyggelse af sekundær hyperparathyroidisme
WO2008131267A2 (en) * 2007-04-18 2008-10-30 Johns Hopkins University Low calcemic, highly antiproliferative, analogs of calcitriol
ES3047207T3 (en) 2007-04-25 2025-12-03 Opko Renal Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
CA2683628C (en) * 2007-04-25 2018-03-06 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
EP2148685A4 (de) * 2007-04-25 2010-07-28 Cytochroma Inc Verfahren und verbindungen für die vitamin-d-therapie
KR101691876B1 (ko) 2007-04-25 2017-01-02 사이토크로마 인코포레이티드 비타민 d 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
ES2593356T3 (es) 2008-04-02 2016-12-07 Opko Ireland Global Holdings, Ltd. Métodos, composiciones, usos y kits útiles para la deficiencia de la vitamina D y trastornos relacionados
WO2011088209A2 (en) * 2010-01-13 2011-07-21 Cytochroma Inc. 1-deoxy analogs of vitamin d-related compounds
WO2011119610A2 (en) 2010-03-23 2011-09-29 Wisconsin Alumni Research Foundation (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1α,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22- DIMETHYL-1α,25-HYDROXYVITAMIN D3
US8664206B2 (en) 2010-03-23 2014-03-04 Wisconsin Alumni Research Foundation Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
US8788551B2 (en) 2011-11-15 2014-07-22 Seagate Technology Llc Random number generation using switching regulators
US9201630B2 (en) 2012-02-10 2015-12-01 Seagate Technology Llc Random number generation using startup variances
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 d 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
KR20180123100A (ko) 2016-03-28 2018-11-14 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법
WO2025094144A1 (en) 2023-11-02 2025-05-08 Eirgen Pharma Ltd. Controlling loss of kidney function

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5119752A (en) 1974-08-07 1976-02-17 Masayuki Ishikawa 1 arufua* 2 arufuaa jihidorokishikorekarushifuerooruno seiho
US4224231A (en) 1979-09-04 1980-09-23 Wisconsin Alumni Research Foundation Derivatives of 25-hydroxycholecalciferol
US4927815A (en) * 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same
JPH0667898B2 (ja) * 1989-02-15 1994-08-31 大同ほくさん株式会社 22,23―セコビタミンd若しくはその活性型またはそれらの誘導体の製造方法
US5401732A (en) 1989-02-23 1995-03-28 Leo Pharmaceutical Products Ltd. A/S Kemiske Fabrik Produkionsaktiese Skab Vitamin D analogues
US4973584A (en) * 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
US5401731A (en) 1989-06-29 1995-03-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) Vitamin D analogues
GB8915770D0 (en) 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
US5260290A (en) 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9015774D0 (en) 1990-07-18 1990-09-05 Leo Pharm Prod Ltd Novel treatment
US5830885A (en) 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
US5274142A (en) 1992-03-12 1993-12-28 The Johns Hopkins University Vitamin D3 analogues
US5403832A (en) 1992-03-12 1995-04-04 The Johns Hopkins University Vitamin D3 analogues
GB9226877D0 (en) 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Chemical compounds
US6043386A (en) 1998-06-03 2000-03-28 John Hopkins University Non-calcemic, antiproliferative, transcriptionally active 24-fluorinated hybrid analogs of 1α,-25-dihydroxy vitamin D3

Also Published As

Publication number Publication date
EP1180035A4 (de) 2003-07-30
MXPA01009693A (es) 2002-03-14
CA2366586A1 (en) 2000-10-12
CA2366586C (en) 2004-06-22
JP3630101B2 (ja) 2005-03-16
JP2002541112A (ja) 2002-12-03
JP3796508B2 (ja) 2006-07-12
DE60031666T2 (de) 2007-08-30
US6380408B1 (en) 2002-04-30
ES2274785T3 (es) 2007-06-01
DE60031666D1 (de) 2006-12-14
EP1745787A3 (de) 2007-02-07
CY1107548T1 (el) 2013-03-13
EP1180035A1 (de) 2002-02-20
EP1745787B1 (de) 2016-11-09
JP2005023087A (ja) 2005-01-27
DK1180035T3 (da) 2007-03-05
WO2000059513A1 (en) 2000-10-12
EP1180035B1 (de) 2006-11-02
PT1180035E (pt) 2007-02-28
EP1745787A2 (de) 2007-01-24
HK1044293B (en) 2007-06-08
HK1044293A1 (en) 2002-10-18
ES2614632T3 (es) 2017-06-01
WO2000059513A8 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
DE60031666D1 (de) NICHT-CALCEMISCHE, TRANSKRIPTIONELL-AKTIVE, SCHWEFELHALTIGE ANALOGA VON 1-alpha, 25-DIHYDROXYVITAMIN D3 MIT ANTIPROLIFERATIVER WIRKUNG
DE60016670D1 (de) Kosmetisches Mittel enthaltend mindestens einen Hydroxystilben und Ascorbinsäure
ATE33503T1 (de) Pharmazeutische und tiermedizinische praeparate von interleukin-2, in dem cystein-125 ausgetauscht worden ist (muteine), sowie deren herstellung.
PT2455083E (pt) Composição farmacêutica para aplicação dérmica compreendendo calcipotriol e betametasona para o tratamento da psoríase
ATE396966T1 (de) Carbocyclische und oxacarbocyclische fumarsaeure- oligomere
CY1109341T1 (el) Διαμορφωτες υποδοχεα βιταμινης d τυπου φαινυλο-θειοφαινιου
ES245929U (es) Dispositivo para el montaje elastico y soporte de una super-estructura dental
ES2136105T3 (es) Preparacion farmaceutica y/o cosmetica.
NL163713C (nl) Samenstel van gebitsprothese en ten minste een samenwerkend implantaat.
ZA945427B (en) Side chain-modified 1alpha-hydroxy vitamin D analogues
ATE155485T1 (de) Bpc-peptide, ihre herstellung und verwendung
LT2004074A (en) Matricines metalproteinazes inhibuojanti kompozicija neoplazinems ligoms gydyti
DK1565422T3 (da) Vitamin-D-receptor-modulatorer
NO882453L (no) T-pa-analog.
ES2131863T3 (es) Derivados de colchicina y su uso terapeutico.
JPS6485079A (en) Tissue plasminogen activating factor analog having improved proliferating factor domain
ATE239700T1 (de) 24,24-difluorierte analogen von 1-alpha,25- dihydroxy vitamin d3
EP0212912A3 (de) Calcitonin-Analoga mit C-terminalen D-Aminosäurensubstituenten
DK0415902T3 (da) Oxy- eller thiosubstituerede fedtsyreanaloger til anvendelse ved behandling af retrovirale infektioner
ES2038729T3 (es) Producto insecticida.
IT1283684B1 (it) Calzatura con struttura di sostegno e irrigidimento e procedimento per realizzare tale calzatura
DE59814311D1 (de) Calicitonin-Analoga mit stark erhöhter hypocalcämischer Wirkung in vivo
GB2000783A (en) Physiologically active enkephalin analogues
YU2394A (sh) Lizin so 6-hloro-5-fluoro-3-(-2-tenoil)-2-oksindol-1-karboksamida
EP0351017A3 (en) Pharmaceutical composition useful for the treatment of cardiovascular diseases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1180035

Country of ref document: EP